Wikisage, the free encyclopedia of the second generation, is digital heritage

Drisapersen: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
Line 6: Line 6:
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]


[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/ Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]


{{refs}}
{{refs}}

Revision as of 23:30, 11 September 2019